The surge in prices boosted shares of miners, which rose 2.9% on Thursday. Energy stocks also gained 1.3% as oil prices ...
Opinion
RFK Jr. is definitely coming for your vaccines (part 7): What, me worry (about polio and HPV)?
Last week was a hellscape for vaccines, with a RICO lawsuit against the AAP and the newly antivax CDC coming for your HPV and polio vaccines.
Search has evolved into a complex, multi-dimensional ecosystem where “being visible” means far more than simply holding the top spot. In 2026, with AI ...
Jan 21 (Reuters) - European shares dipped on Wednesday, deepening a selloff sparked by renewed trade tensions linked to ...
Abstract: Recent studies on integrating multiple omics data highlighted the potential to advance our understanding of the cancer disease process. Computational models based on graph neural networks ...
UN Data serves as a unified platform that brings together statistical data from across the UN system, with the goal of becoming the primary integrated source of trusted UN statistics and data.
Microsoft Graph has a set of command line tools that can be integrated into Microsoft 365 to manage users and apps as well as automate tasks. For an organization with a Microsoft 365 tenant, managing ...
Copangraph is designed to represent the pan-metagenomic content across multiple metagenomic samples as a sequence graph. By doing so, it provides the foundation of a ...
London-listed Taylor Maritime has agreed yet another bulker sale, lifting its total disposals since 2023 to an impressive 50 vessels. The Edward Buttery-led operation completed the sales of four ...
Microsoft Corp will discontinue its Graph command-line interface tool next year, citing declining usage and overlap with existing developer tools as the company consolidates its software development ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Non-Commercial (NC): Only non-commercial uses of the work are permitted. No ...
Introduction: This meta-analysis was designed to compare the long-term outcomes of first-line cyclin-dependent kinase 4/6 (CDK4/6) inhibitors plus endocrine therapy (ET) versus ET in patients with HR+ ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果